首页> 美国卫生研究院文献>Scientific Reports >Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment
【2h】

Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment

机译:幼稚的CD8 + T细胞衍生的肿瘤特异性细胞毒性效应子可作为克服肿瘤微环境中TGF-β免疫抑制的潜在药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite of the potential implications for cancer immunotherapy, conventional approaches using in vitro expanded CD8+ T cells have suboptimal outcomes, mostly due to loss of functionality from cellular exhaustion. We therefore investigated the phenotypic and functional differences among in vitro activated CD8+ T cells of three different sources, namely naïve (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations. In line with the greater proliferation activity and longer telomere lengths of NTeff populations, cells of naïve origin exhibited significantly less amounts of T cell exhaustion markers than those of MTeff and TILeff, and moreover, acquired distinct expression patterns of memory-promoting transcription factors, T-bet and Eomes, induced in a rapid and sustainable manner. NTeff cells appeared to have lower expression of Foxp1 and were refractory to apoptosis upon TGF-β conditioning, implying better survival potential and resistance to tumor-induced immune suppression. Of CD8+ T cell pools activated to tumor-specific CTLs, naïve cell generated effectors possessed the most potent cytotoxic activity, validating implications for use in rational design of adoptive immunotherapy.
机译:尽管可能对癌症免疫疗法产生影响,但使用体外扩增的CD8 + T细胞的常规方法仍未达到最佳效果,这主要是由于细胞衰竭导致的功能丧失。因此,我们研究了三种不同来源的体外活化CD8 + T细胞在人类和小鼠的幼稚(NTeff),记忆(MTeff)和肿瘤浸润淋巴细胞(TILeff)之间的表型和功能差异,以更好地了解有效的效应子功能背后的机制以及克服当前局限性的潜力。与NTeff种群具有更高的增殖活性和更长的端粒长度相一致,与MTeff和TILeff相比,幼稚来源的细胞表现出的T细胞衰竭标记数量明显减少,此外,获得了记忆促进转录因子T的独特表达模式-bet和Eomes,以快速且可持续的方式产生。 NTeff细胞似乎具有较低的Foxp1表达,并且在TGF-β调节后难以凋亡,这意味着更好的生存潜力和对肿瘤诱导的免疫抑制的抵抗力。在激活至肿瘤特异性CTL的CD8 + T细胞库中,未产生过细胞的效应物具有最强的细胞毒性活性,验证了在合理设计过继免疫疗法中的应用意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号